heartwire News


  • ACC 2018 Sanjay Kaul Grades Four Big Trials From ACC 2018 Dr Kaul rates trials on alirocumab, black barbershop-based healthcare, canakinumab, and the wearable cardioverter defibrillator, from the 2018 American College of Cardiology Scientific Sessions.
  • Pharmacists and Barbers on the Cutting Edge of Medicine Dr Mandrola's hands-down favorite study from the 2018 American College of Cardiology meeting showed that a pharmacist-led intervention in black-owned barbershops cut hypertension in black men.
  • How to Assess and Manage Stroke Risk in Atrial Fibrillation?   Drs Acharya, Friedman, and Klaas discuss when to anticoagulate patients with atrial fibrillation; additional factors that contribute to stroke risk; and treatment options for stroke prevention.
  • The Slam Dunk NSTEMI That Was Almost an Epic Fail Using a basketball analogy, Dr Walton-Shirley describes a case that bounced around a number of healthcare professionals who almost 'dropped the ball.'
также читайте